Pillar Biosciences

Making precision medicine the first option for every patient

[Pillar Biosciences @Pillar_Bio]

Less than 10 days to the 2023 AACR Annual Meeting. Please join us at Booth #2343 to learn more about how our portfolio of oncoReveal kitted solutions can reduce #NGS failures and drive actionable, accessible results to everyone, everywhere. #AACR2023

[Pillar Biosciences @Pillar_Bio]

Pillar Biosciences Receives College of American Pathologists (CAP) Accreditation

https://t.co/uCKuir13MN

[Pillar Biosciences @Pillar_Bio]

#AMPath2022 starts today! Join our corporate workshop where we’re diving into how Pan-Cancer #NGS testing benefits pathologists & oncologists and check our posters showcasing scientific data on our SLIMamp® technology. Register here: https://t.co/CNbeBWCc7Y

[Pillar Biosciences @Pillar_Bio]

Join us #AMPath2022, where we’re presenting scientific data on our SLIMamp® technology and holding a corporate workshop to discuss how Pan-Cancer #NGS testing can help pathologists and oncologists obtain reliable and rapid clinical results. Register here: https://t.co/BbbMdyyfmq

[Pillar Biosciences @Pillar_Bio]

Pillar will be at #AMPath2022! Check out our corporate workshop, posters and visit booth #839 to learn how we’re enabling improved Decision Medicine™ through our SLIMamp RUO & IVD NGS kit solutions to drive localized, actionable and accessible results to everyone, everywhere.

[Pillar Biosciences @Pillar_Bio]

You are invited to an exclusive event hosted by @Pillar_Bio and Pierian on November 3rd from 7-10 PM.

Join us for complimentary drinks and appetizers, with an opportunity to network with industry’s pioneers and experts in clinical genomics and #NGS

https://t.co/Iqto3dsnuU

[Pillar Biosciences @Pillar_Bio]

Happening today! Our webinar about #NGS testing with @endpts starts at 11 a.m. ET. Join CEO, Randy Pritchard and @ColumbiaPath’s Helen Fernandes, Ph.D. to discuss how localizing NGS testing increases efficiency in treating #cancer. Register here for free: https://t.co/T4VtT7NIHj

[Pillar Biosciences @Pillar_Bio]

This Wednesday, join our free webinar with Pillar CEO Randy Pritchard & @ColumbiaPath’s Helen Fernandes to discuss how the current state of #cancer care can be transformed by localized next-generation sequencing (#NGS) testing technologies. Register here: https://t.co/NBiGlN5Fqk

[Pillar Biosciences @Pillar_Bio]

Our free webinar about Next-Generation Sequencing (#NGS) testing with @endpts, is 2 weeks away. Join CEO, Randy Pritchard &@ColumbiaPath’s Helen Fernandes, Ph.D. to discuss how localizing NGS testing increases efficiency in treating #cancer. Register here: https://t.co/yDd1fEOvtI

[Pillar Biosciences @Pillar_Bio]

Join us on 9/28 for an educational webinar where Helen Fernandes, Ph.D., of @ColumbiaPath & @Pillar_Bio CEO Randy Pritchard will discuss clinical challenges & opportunities associated with NGS testing today.

Click here to register: https://t.co/gXRrup5YQK

[Pillar Biosciences @Pillar_Bio]

Join us on September 28th from 11:00 am to 12:00 pm EDT to learn more about how @Pillar_Bio is enabling the future of “Decision Medicine” - Endpoints Webinars https://t.co/GwjszVXejI by @endpts

[Pillar Biosciences @Pillar_Bio]

We’re pleased to announce that China’s National Medical Products Administration (NMPA) has approved our oncoReveal™ Dx Colon Cancer Assay as a companion diagnostic. Learn more: https://t.co/ROxRmPp5fy

[Pillar Biosciences @Pillar_Bio]

This week at the @UBS Genomics 2.0 and MedTech Innovations Summit, our CEO Randy Pritchard is participating in the Liquid Biopsy in Clinical Practice panel discussion and investor meetings. Learn more: https://t.co/aBScrljPrP

[Pillar Biosciences @Pillar_Bio]

We're pleased that the @US_FDA has accepted for review the company’s PMA supplement application for its Pan-cancer oncoReveal™ CDx. If approved, the label/indication of its Lung & Colon Cancer Assay will expand to include targets for 8 more #cancer types. https://t.co/oMMo5Nf3ui

[Pillar Biosciences @Pillar_Bio]

At @Pillar_Bio we believe that we grow together collectively as a team. We asked Martin Larke, Senior Scientist on the R&D team to describe his journey with us.

Want to join the Pillar team? Check out our current openings: https://t.co/OQTUrpAzAc

[Pillar Biosciences @Pillar_Bio]

Pillar is proud to be part of a community supporting survivors of lung cancer, and is committed to helping the #ILCSC fulfill its mission.
#lungcancer #LCSM #ILCSC22

[LUNGevity Foundation @LUNGevity]

The 12th annual International Lung Cancer Survivorship Conference starts at 10:30am ET. Hear from keynote speaker @DCarboneMD. Sessions will be ready to watch 3 business days after. Be sure to tag us when sharing your photos and use #ILCSC22. https://t.co/p6xkn4Q22l. #LCSM

[Pillar Biosciences @Pillar_Bio]

Join the Pillar team!
Check out our current openings: https://t.co/hjPwt2FyR9
#hiring #sciencejobs #wearehiring #remotejobs #pillarteam

[Pillar Biosciences @Pillar_Bio]

Check out @Pillar_Bio positions
https://t.co/RQ3FXJL9Jk
Comment or message if you are interested in learning more!
#hiring #biosciencejobs #softwarejobs #scientistjobs

[Pillar Biosciences @Pillar_Bio]

☀️😎Best wishes and Happy Independence Day from @Pillar_Bio 🇺🇸
Yesterday we celebrated together with a BBQ Pot-Luck!
#independenceday #4thofjuly #independencedayusa #employeeappreciation #employeegathering #celebration

[Pillar Biosciences @Pillar_Bio]

Join the Pillar team!
Check out our current openings: https://t.co/dDSZUtuJKE
#hiring #biosciencejobs #biotechjobs